As of 2026-09-26, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (52.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -72451.0%.
The range of the Relative Valuation is (57.62) - (41.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 37.1x | 34.0x |
| Forward P/E multiples | 21.6x - 22.2x | 21.9x |
| Fair Price | (57.62) - (41.53) | (52.24) |
| Upside | -79899.9% - -57618.1% | -72451.0% |
| Date | P/E |